Cargando…
The development of bispecific antibodies and their applications in tumor immune escape
During the past two decades, a great evolution of bispecific antibodies (BsAbs) for therapeutic applications has been made. BsAbs can bind simultaneously two different antigens or epitopes, which leads to a wide range of applications including redirecting T cells or NK cells to tumor cells, blocking...
Autores principales: | Zhang, Xiaolong, Yang, Yuanyuan, Fan, Dongmei, Xiong, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414286/ https://www.ncbi.nlm.nih.gov/pubmed/28469973 http://dx.doi.org/10.1186/s40164-017-0072-7 |
Ejemplares similares
-
Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015) -
Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan
por: Zhang, Xiaolong, et al.
Publicado: (2017) -
Recent advances of bispecific antibodies in solid tumors
por: Yu, Shengnan, et al.
Publicado: (2017) -
Development of bispecific antibodies in China: overview and prospects
por: Zhang, Jing, et al.
Publicado: (2020) -
Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
por: Register, Ames C., et al.
Publicado: (2021)